PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Trial PAR008 is on ANZCTR, page-14

  1. 4,218 Posts.
    lightbulb Created with Sketch. 6699
    Yes...perhaps not necessarily focused entirely on DMOAD but certainly as a remarkable observation.

    Take a look at this post:

    https://hotcopper.com.au/threads/the-phd-no-and-the-dmoad-magic-of-ipps.5813276/


    Specifically there was a study on canines (I've called it Study 2 in the post above).
    An example quote was:

    "...the findings of this study confirmed PPS as a novel suitable alternative chondroinductive factor to known chondrocytic growth factors that may offer a solution to the inherent challenges faced in cartilage tissue regeneration and repair of small OA cartilage lesions."



    Chrondoinductive factor offering a solution in cartilage tissue regeneration was probably a big clue for us investors.





    Another example without spending too much time digging was the experiment with Donkeys...the show me the Mozz Money quote here was:

    "PSGAGS also contributes to cartilage healing by providing the body with the building blocks of cartilage."






    As a final example I give you my recent James Bond Piece with this illustrative and eye opening quote in terms of DMOAD potential:


    " NaPPS resulted in significant improvement in clinical signs and articular cartilage healing, and no adverse effects were detected confirming that NaPPS has disease-modifying properties"



    Pool-Boss, there have been a few examples of other research I have come across over the months that have come to the conclusion of DMOAD properties and hints of our magical iPPS wonder drug.






    DYOR






 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $103.1M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.